Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Arch Dermatol Res ; 314(7): 673-679, 2022 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34251536

RESUMEN

Adapalene is used for treatment of acne vulgaris, a common dermatological disease. Nano-based carriers have been developed to improve solubility and bioavailability of adapalene and other acne treatment drugs. In our previous report, tea tree oil nanoemulsion containing adapalene gel (TTO NE + ADA Gel) showed appropriate physical and biological properties such as stability, viscosity, pH, size, morphology and biocompatibility in an animal model. The present study was designed to assess efficacy and safety of the TTO NE + ADA Gel in comparison with 0.1% adapalene marketed gel (ADA Marketed Gel). A total of 100 patients were randomized to receive TTO NE + ADA Gel or ADA Marketed Gel, once daily at night, for 12 weeks. Analysis for efficacy was conducted by acne lesion count (total, inflammatory and non-inflammatory) and acne severity index at weeks 4, 8 and 12 using generalized estimating equation along with the safety assessments in each measurement for assessing dryness, erythema, burning sensation and irritation. Significantly better reduction in total, inflammatory, and non-inflammatory acne lesions were reported for TTO NE + ADA Gel as compared to the ADA Marketed Gel overall and on each measurement occasion (p value < 0.001 for all). Mean acne severity index also reduced with TTO NE + ADA Gel significantly in comparison with ADA Marketed Gel (p value < 0.001). Dryness was the most common adverse effect reported in both groups and it was higher in TTO NE + ADA Gel group. In conclusion, TTO NE + ADA Gel compared to ADA Marketed Gel appears more effective in the treatment of acne vulgaris, with no important change in adverse effects.


Asunto(s)
Acné Vulgar , Fármacos Dermatológicos , Aceite de Árbol de Té , Acné Vulgar/tratamiento farmacológico , Acné Vulgar/patología , Adapaleno/uso terapéutico , Animales , Fármacos Dermatológicos/efectos adversos , Geles/uso terapéutico , Naftalenos/efectos adversos , Aceite de Árbol de Té/efectos adversos , Resultado del Tratamiento
2.
Med Hypotheses ; 133: 109409, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31581031

RESUMEN

Acne vulgaris is a common disease which affects about 85% of the population. Various topical drugs are available, but the retinoid derivatives are mostly taken into consideration. They are used as a first-line treatment drugs. However, they also have few side effects. Whereas, adapalene which is a third generation topical retinoid has fewer side effects compared to other derivatives. In this, we hypothesize that the combination therapy of adapalene and flavonoid could improve the efficacy and thereby it can also decrease the treatment time. Since, flavonoids possess multiple activities we assume that it can improve the action of the drug by showing a synergistic activity. Moreover, when we incorporate these two drugs in nanoemulgel, it can easily penetrate into the skin and produce its therapeutic action. Hence, we assume that if this hypothesis proves to be correct then this method will be an effective one in treating acne (pustule).


Asunto(s)
Acné Vulgar/tratamiento farmacológico , Adapaleno/uso terapéutico , Polifenoles/uso terapéutico , Acné Vulgar/fisiopatología , Adapaleno/administración & dosificación , Animales , Antiinflamatorios/administración & dosificación , Antiinflamatorios/uso terapéutico , Fármacos Dermatológicos/clasificación , Fármacos Dermatológicos/uso terapéutico , Modelos Animales de Enfermedad , Combinación de Medicamentos , Evaluación Preclínica de Medicamentos , Sinergismo Farmacológico , Emulsiones , Femenino , Humanos , Masculino , Ratones , Nanogeles , Polifenoles/administración & dosificación , Conejos , Ratas , Receptores de Ácido Retinoico/agonistas
3.
J Dermatol ; 44(4): 401-405, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27743393

RESUMEN

The standard management of acne vulgaris in Japan includes a combination of topical treatment with benzoyl peroxide (BPO) and BPO/clindamycin (CLDM), topical adapalene and systemic antimicrobials. However, the treatment of therapy-resistant complications such as postinflammatory hyperpigmentation (PIH), erosions with inflamed red papules and atrophic scars has not been established. We performed chemical peeling with glycolic acid and iontophoresis with ascorbyl 2-phosphate 6-palmitate and DL-α-tocopherol phosphate for the treatment of PIH, erosions with inflamed red papules and non-inflamed atrophic scars in 31 patients with acne vulgaris (mild to severe severity), and evaluated the efficacy and safety of these interventions. In most of cases, there was remarkable improvement in PIH and erosions with inflamed red papules after treatment. There was also some improvement in non-inflamed atrophic scars without erythema. Mild redness and irritation was observed in four cases as adverse reactions. Early initial treatment of PIH and erosions with red papules by chemical peeling and iontophoresis is an effective and safe method to prevent the formation of atrophic scars in patients with acne vulgaris.


Asunto(s)
Acné Vulgar/complicaciones , Acné Vulgar/terapia , Quimioexfoliación/efectos adversos , Cicatriz/terapia , Eritema/terapia , Hiperpigmentación/terapia , Iontoforesis/efectos adversos , Adapaleno/uso terapéutico , Adolescente , Adulto , Antiinfecciosos/uso terapéutico , Ácido Ascórbico/administración & dosificación , Ácido Ascórbico/efectos adversos , Ácido Ascórbico/análogos & derivados , Ácido Ascórbico/uso terapéutico , Atrofia , Peróxido de Benzoílo/uso terapéutico , Cicatriz/patología , Clindamicina/uso terapéutico , Terapia Combinada , Femenino , Glicolatos/administración & dosificación , Glicolatos/efectos adversos , Glicolatos/uso terapéutico , Humanos , Japón , Masculino , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Adulto Joven , alfa-Tocoferol/administración & dosificación , alfa-Tocoferol/efectos adversos , alfa-Tocoferol/análogos & derivados , alfa-Tocoferol/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA